DLA Piper Guides Takeda In €520M Biopharma Acquisition
Takeda Pharmaceutical Co. said Friday it is putting a plan in motion to take over Belgian biopharmaceutical company TiGenix NV with an approximately €520 million ($626 million) deal, steered by DLA...To view the full article, register now.
Already a subscriber? Click here to view full article